News about Biotechnology, Pharmaceutical and Healthcare

20:27 EDT 1st August 2014 | BioPortfolio

Latest news articles in the life-science, healthcare, medical device, biotechnology and pharmaceuticals sectors. 

Showing News Articles 1–25 of 8,200+

Friday 1st August 2014

Clean Power Plan draws all kinds to testify before EPA

The Colorado Independent Tessa Cheek July 30, 2014 BY NOON on Tuesday it’s blisteringly bright in downtown Denver and the children of Climate Parents are squinting while they toss around miniature inflatable globes. A prop plane roars low overhead, collecting air quality samples. “That plane only underscor

Thermo Fisher Scientific Transforms Chromatography by Reimagining UHPLC

Thermo Fisher Scientific, the world leader in serving science, today unveiled a new high performance liquid chromatography system designed from the ground up to provide new levels of performance, productivity and usability when used as a standalone system or with the latest mass spectrometers. The new Thermo Scientific Vanquish UHPLC looks different from standard UHPLC systems, and there are benef...

Simple Weighing with the New Sartorius Entris Balance

Sartorius introduces the new Entris, a balance that focuses on the most commonly used weighing applications and dispenses with costly additional functions. The Entris analytical and precision balance is available in 15 models, covering a weighing capacity from 60 g to 8,200 g with a readability of 0.1 mg to 0.1 g. With Entris, users get a reliable balance in the well-known Sartorius quality. Most...

Minister calls for end of animal testing

UK MP Norman Baker has called for an end to all animal testing in the UK and promised to increase transparency about the use of animals. The Lib Dem, a long standing anti-vivisection campaigner and the minister responsible for regulating the use of animals in science says he understood ‘it would not happen tomorrow’, but was trying to convince the industry of the economic as well as moral case...

Freeman Technology to Present ‘Choosing a Powder Tester’ at Powtech 2014

At Powtech 2014, Freeman Technology, the powder characterisation specialists, will present ‘Choosing a Powder Tester’. When evaluating powder testers, there is no shortage of options; this new booklet provides guidance on selecting the most suitable instrumentation. It considers questions such as ‘what makes powder testing complex?’ and ‘what should I look for in a p...

New Rapid Assay Detects Cytomegalovirus

New Iam CMV provides speed and accuracy for the diagnosis and monitoring of CMV infection in immunocompromised patients DiaSorin strengthens its infectious disease diagnostic portfolio with the launch of the Iam CMV assay for the molecular detection and quantification of cytomegalovirus. DiaSorin has further expanded its range of infectious disease assays for use on the DiaSorin Liaison® Iam a...

CLSI Releases New Edition of Standard on Quality Control of Microbiological Transport Systems

The Clinical and Laboratory Standards Institute (CLSI) released a new edition of its document,Quality Control of Microbiological Transport Systems; Approved Standard—Second Edition (M40-A2). This document provides criteria to assist manufacturers and end users of transport devices in providing and selecting dependable products for the transport of microbiological clinical specimens. The tra...

Genomes Project gains £300m UK funding boost

A new funding stream aimed at helping British scientists map human DNA code will ‘revolutionise medicine’, according to prime minister David Cameron. Announcing the plans today, Cameron says the 100,000 Genomes Project, funded by a package of deals now worth £300 million, will “see the UK lead the world in genetic research within year”. It was first announced a year ago by the prime minst...

Boehringer’s Striverdi gains FDA approval

Boehringer Ingelheim’s new lung drug Striverdi has gained US approval for patients with chronic obstructive pulmonary disorder. Striverdi Respimat (olodaterol), which comes as an inhalation spray, is now licensed to treat patients with COPD, including chronic bronchitis and/or emphysema, who are experiencing airflow obstruction. COPD is a serious lung disease that makes breathing difficult and w...

FDA accepts biosimilar filgrastim application

Sandoz, the generic drug division of Swiss drug giant Novartis, announced on 24 July 2014 that the US Food and Drug Administration (FDA) had accepted its application for approval of the company’s biosimilar filgrastim product.

Biosimilars of darbepoetin alfa

Darbepoetin alfa is a synthetic form of erythropoietin. It stimulates erythropoiesis (increases red blood cell levels) and is used to treat anaemia, commonly associated with chronic renal failure and cancer chemotherapy.

Data protection provisions in CETA

The trade agreement between the European Union (EU) and Canada has the potential to have a negative affect on the generics industry in Canada [1]. In particular, certain intellectual property provisions are seen as the main culprits.

Phase I studies of infliximab and rituximab biosimilars demonstrate pharmacokinetic similarity

Results of phase I trials of pharma giant Pfizer’s biosimilar infliximab and rituximab candidates have demonstrated similar pharmacokinetic properties compared to the originator products [1, 2].

EC expected to dish out more pay-for-delay finesEC expected to dish out more pay-for-delay fines

The European Commission (EC) is planning to fine French drugmaker Les Laboratoires Servier (Servier) and generics giant Teva Pharmaceutical Industries (Teva) in its latest round of investigations over so-called ‘pay-for-delay’ deals.

Healthcare providers concerned about FDA’s generics labelling rules

A survey by the Generic Pharmaceutical Association (GPhA) and the National Coalition on Healthcare (NCH) has revealed that healthcare providers have serious concerns about the US Food and Drug Administration’s (FDA) proposed new rules for generics...

Generic valsartan approved in US

India’s largest generics maker Ranbaxy Laboratories announced on 27 June 2014 that its subsidiary, US-based Ohm Laboratories (Ohm), had received approval from the US Food and Drug Administration (FDA) for generic valsartan.

India planning to extend pricing control to more drugs

India is thought likely to increase the number of drugs it considers ‘essential’ and therefore for which it controls the maximum retail price in the country.

Endo to buy generics maker DAVA

Specialty pharmaceuticals maker Endo Health Solutions (Endo) announced on 24 June 2014 that it had reached a definitive agreement to acquire generics maker DAVA Pharmaceuticals for US$575 million in cash, with another US$25 million up for grabs depen...

Thursday 31st July 2014

Braingaze gets pre-seed funding to fuel growth

The Barcelona-based company will invest the capital in R&D&i, product development, patent consolidation and app development

American David Tilman wins tenth Ramon Margalef Award for Ecology

El científico ha destacado por su investigación sobre los efectos de la biodiversidad en el funcionamiento de los ecosistemas

ChargePoint swoops for key supplier

ChargePoint Technology, the Liverpool-based manufacturer which supplies precision containment valves to some of the world’s largest pharmaceutical and chemicals businesses, has today acquired the assets of Forac Limited, a key business in its s...

THERAPEUTISCHE PARKINSON-IMPFUNG: Entscheidung zur Weiterentwicklung dank erster klinischer Daten

Die AFFiRiS AG veröffentlicht Phase I-Daten einer first-of-its-kind-Behandlung, die mit Unterstützung der Michael J. Fox Foundation entwickelt wird (NEW YORK, WIEN) 31. Juli, 2014 – Die AFFiRiS AG gab heute auf einer Pressekonferenz in New York E...

Early treatment benefits infants with severe combined immunodeficiency

NIH-funded study identifies factors contributing to successful stem cell transplants.

Know-how-Schub für Humantechnologie

“QnHT 2.0″ startet mit 19 Partnerunternehmen Graz (OTS) – Auf Basis der spezifischen Bedarfe der beteiligten Unternehmen wurde im Oktober 2012 das erste “Qualifizierungsnetz Humantechnologie (QnHT)” ins Leben gerufen. Da...

New report on “Best Available Techniques (BAT) and Best Practices for the Health Sector”

This report is one of the first outputs of the LIFE+ BOHEALTH project


Search BioPortfolio:
Advertisement
Advertisement